US Stock MarketDetailed Quotes

EZPW EZCORP

Watchlist
  • 13.180
  • -0.160-1.20%
Close Mar 10 16:00 ET
724.09MMarket Cap11.56P/E (TTM)

EZCORP Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

EZCORP Q1 2025 Earnings Date

Currency：USDFeb 5, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
322.83M
320.17M
-2.66M
Miss Est.
+7.61%
+6.73%
-0.82%
EPS
0.35
0.40
+0.05
Beat Est.
-1.86%
+11.11%
+13.22%
Analyst Rating
Buy

Feb 28, 2025

EZCORP Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 301.393M--
--2025/Q2-- / 310.462M--
Feb 5, 20252025/Q1320.170M / 322.828M--
Nov 13, 20242024/Q4294.551M / 290.263M--
Jul 31, 20242024/Q3281.421M / 279.547M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 301.393M--
--2025/Q2-- / 310.462M--
Feb 5, 20252025/Q1320.170M / 322.828M--
Nov 13, 20242024/Q4294.551M / 290.263M--
Jul 31, 20242024/Q3281.421M / 279.547M--

Unlock Free Earnings Estimates

EZCORP Earnings Reports

  • EZCORP | 8-K: EZCORP Reports First Quarter Fiscal 2025 Results

    Feb 5 16:55 ET

  • EZCORP | 10-Q: Q1 2025 Earnings Report

    Feb 5 16:51 ET

  • EZCORP | 8-K: EZCORP Reports Fourth Quarter and Full Year Fiscal 2024 Results

    Nov 13, 2024 17:17 ET

  • EZCORP | 10-K: FY2024 Annual Report

    Nov 13, 2024 17:12 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Lantheus
    LNTH
    +3.45%
    Collegium Pharmaceutical
    COLL
    +2.59%
    Constellation Brands
    STZ
    +1.73%
    Halozyme Therapeutics
    HALO
    +0.75%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data